Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A number of diverse treatments are available for patients with coronary disease. These include, but are not limited to, diet regulation, weight loss, medication, and surgical procedures such as angioplasty, ablation, revascularization, or coronary artery bypass surgery.
The CDC has recognized that familial hypercholesterolemia (FH) is a huge health problem and The CDC has classified it as a "Tier 1" disease, meaning it has huge health implications with already existing, highly effective therapies. The good news is that FH is often treatable. With early screening and diagnosis in addition to a proper diet and medication regimen, those with FH are able to live longer, healthier lives.
Learn about heart disease prevention tips, how diet and cholesterol play a role in heart disease, and using genetics to improve cardiac health.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.